Tom Adriaenssens, MD, PhD

Complex Bifurcation Lesions: Randomized Comparison of Modified-T Stenting vs Reconstruction With Self-Expanding Stent and Bioresorbable Scaffold: COBRA II

04/01/2021

Walter Desmet , MD, PhD;

Johan Bennett , MD, PhD;

Christophe Dubois , MD, PhD;

Keir McCutcheon , MD, PhD;

Maarten Vanhaverbeke , MD, PhD;

Ruben Pauwels , MD;

Tom Adriaenssens , MD, PhD;

Peter Sinnaeve , MD, PhD;

We evaluate the role of a double bioresorbable vascular scaffold (BVS) strategy in coronary bifurcations, alone or in combination with a dedicated bifurcation device.

We evaluate the role of a double...

04/01/2021

Journal of Invasive Cardiology

Early Drug-Eluting Stent Restenosis Due to Aggressive Neoatherosclerotic Degeneration, an Optical Coherence Tomography Finding

07/01/2013

Johan Bennett , MD, PhD;

Christophe Dubois , MD, PhD;

Giovanni Jacopo Ughi , PhD;

Bert Ferdinande , MD;

Tom Adriaenssens , MD, PhD;

We report a case of unusually early in-stent restenosis in a drug-eluting stent due to likely aggressive neoatherosclerotic degeneration.

We report a case of unusually...

07/01/2013

Cath Lab Digest

Case Report

Successful Stenting of Bilateral Multiple Renal Arteries in a
Patient with Renovascular Hypertension

08/01/2008

Tom Adriaenssens , MD, PhD;

Adnan Kastrati , MD;

Albert Schmig , MD;

Renal artery stenosis (RAS) can result in renovascular hypertension and nephrosclerosis, and accounts for approximately 1 to 3% of all causes of hypertension. The current treatment of choice for atherosclerotic renal artery disease in...

Renal artery stenosis (RAS) can...

08/01/2008

Journal of Invasive Cardiology

Clinical Images

Left Main Coronary Artery Compression in Pulmonary Hypertension: Value of Multimodality Imaging in Diagnosis and Treatment

12/01/2022

Leticia Barrios , MD;

Marion Delcroix , MD, PhD;

Steven Dymarkowski , MD, PhD;

Johan Bennett , MD, PhD;

Tom Adriaenssens , MD, PhD;

A 43-year-old woman with pulmonary arterial hypertension associated with atrial septal defect, surgically repaired 5 years ago, and treated with the endothelin receptor antagonist macitentan monotherapy due to phosphodiesterase-5-inhibitor...

A 43-year-old woman with...

12/01/2022

Journal of Invasive Cardiology